Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Alkermes | Japan
Show Display Options
Rank Status Study
1 Completed A Study for Patients With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Human Insulin Inhalation Powder;   Drug: Injectable Insulin
2 Completed A Study for Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Neutral protamine hagedorn insulin

Study has passed its completion date and status has not been verified in more than two years.